Pafenolol
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263131This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5AEP5YJ9MZ. European Medicines Agency schedules Pafenolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09585MIG. Pafenolol generally arises in the molecular formula C18H31N3O3. The term PAFENOLOL is an International Non-Proprietary Name or INN. PAFENOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pafenolol under HS 29242190 and SITC 51473. As of Q4 2014, PAFENOLOL remains the US FDA Preferred Term for this commodity. Pafenolol bears US NLM identifiers UMLS ID C0069942 and NCI Concept Code C66291. SMILES: O(CC(O)CNC(C)C)C1CCC(CCNC(=O)NC(C)C)CC1.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.